Lymphedema Global Clinical Trials Review, H2, 2013

GlobalData
November 15, 2013
62 Pages - SKU: GBDT5154673
Colon Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Colon Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Colon Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Colorectal Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
Esophageal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Esophageal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Esophageal Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Hormone Refractory Breast Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive  |  read more...
USD 2,000
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer- Market Analysis, Global API Manufacturers and  |  read more...
USD 2,000
Metastatic Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Metastatic Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Metastatic Pancreatic Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about  |  read more...
USD 2,000
Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Pancreatic Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
Smoking Cessation Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Smoking Cessation Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Smoking Cessation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
Thyroid Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
Thyroid Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 SUMMARY DelveInsight’s, “ Thyroid Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III  |  read more...
USD 2,000
CCR1 Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
CCR1 Inhibitors -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“CCR1 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!